Skip to main content

Table 2 Clinical outcomes of patients hospitalized with AECOPD: Overall and by diabetes status

From: Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry

 

Total (N = 5334)

Diabetes (N = 572)

No diabetes (N = 4762)

P value

Direct hospitalization cost

   

< 0.001

 N (missing)

5315 (19)

570 (2)

4745 (17)

 

 Median (IQR) (RMB, ¥)

9827.5 (7088.1, 13,890.0)

11,088.6 (8032.0, 15,545.2)

9672.5 (7045.1, 13,640.0)

 

Length of Stay, N (%)

   

0.017

 N (missing)

5315 (19)

567 (5)

4748 (14)

 

 ≤ 10

2886 (54.3)

281 (49.6)

2605 (54.9)

 

 > 10

2429 (45.7)

286 (50.4)

2143 (45.1)

 

CAT score at discharge, N (%)

   

0.306

 N (missing)

5334 (14)

572 (1)

4749 (13)

 

 0–10

2242 (42.1)

225 (39.4)

2017 (42.5)

 

 11–20

2527 (47.5)

284 (49.7)

2243 (47.2)

 

 21–30

522 (9.8)

61 (10.7)

461 (9.7)

 

 31–40

29 (0.5)

1 (0.2)

28 (0.6)

 

In-hospital death, N (%)

   

0.327

 N (missing)

5334 (0)

572 (0)

4762 (0)

 

 Yes

8 (0.1)

0 (0.0%)

8 (0.2)

 

 No

5326 (99.9)

572 (100.0)

4754 (99.8)

 
  1. AECOPD: Exacerbation of chronic obstructive pulmonary disease; CAT: COPD assessment test; IQR: Interquartile range